Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) announced in Q4 CY2025, but sales fell by 6.2% year on year ...

SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations ...

Health Catalyst (HCAT) reported $74.68 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 6.2%. EPS of $0.08 for the same period compares to $0.04 a year ...

Q4 2025 Earnings Call March 12, 2026 5:00 PM EDTCompany ParticipantsMatt Hopper - Senior VP of Finance & Head of ...

Detailed price information for Applovin Corp Cl A (APP-Q) from The Globe and Mail including charting and trades.

About Health CatalystHealth Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, ...

Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and year end 2025 ...

Health Catalyst made news on a couple different fronts this week, as it announced its plans to acquire Yakima, Washington-based Vitalware and entered a long-term strategic-analytics partnership with ...

Health Catalyst has acquired Health Care DataWorks, a company with roots in Ohio State University, and one that works on improving patient outcomes much like Health Catalyst does. The deal means that ...

Earnings call Health Catalyst reported Q4 2025 revenue of $74.7M (down YoY), with full-year revenue up 1% to $311.1M and Adjusted EBITDA up 59% to $41.4M. Despite strong cost control and margin gains, ...